Doctors Join the Climate Lobby: Don't they know that poverty kills far more people than heat does?
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 18
- Publication type:
- Article
Works matching IS 21534888 AND DT 2021 AND VI 12 AND IP 5
Results: 20
1
2
Biden's Price Controls Will Make Good Health More Expensive: Pharmaceutical innovation will suffer and drugs that could save your life may not reach the market.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 18
- By:
- Publication type:
- Article
3
New Saliva Test Can Detect HPV-Associated Head and Neck Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 17
- By:
- Publication type:
- Article
4
Multicancer Detection: The Need for Clinical Guidance.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 16
- By:
- Publication type:
- Article
5
Role of Radiology in Intrahepatic Cholangiocarcinoma Addressed at the 2021 Interventional Oncology Meetings.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 14
- Publication type:
- Article
6
Neoadjuvant Nivolumab plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable NSCLC.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 13
- By:
- Publication type:
- Article
7
Sotorasib Shows Encouraging Activity in Patients with NSCLC and KRAS p.G12C Mutation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 12
- By:
- Publication type:
- Article
8
Copanlisib plus Rituximab Prolongs Survival in Relapsed Indolent Non-Hodgkin Lymphoma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 11
- By:
- Publication type:
- Article
9
Daratumumab in Newly Diagnosed Multiple Myeloma: Weighing the Pros and Cons.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 10
- By:
- Publication type:
- Article
10
FDA Approves Keytruda for High-Risk, Early-Stage, Triple-Negative Breast Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 12
- Publication type:
- Article
11
Tibsovo First Targeted Therapy FDA Approved for Advanced or Metastatic Cholangiocarcinoma with IDH1 Mutation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 11
- Publication type:
- Article
12
Brukinsa Now Approved for Waldenström's Macroglobulinemia.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 9
- Publication type:
- Article
13
FDA Approves Rezurock for the Treatment of Chronic Graft-versus-Host Disease.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 7
- Publication type:
- Article
14
Tucatinib plus Trastuzumab and Capecitabine Triplet Maintains Survival Benefit in HER2-Positive Metastatic Breast Cancer: Updated Results from HER2CLIMB Trial.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 7
- By:
- Publication type:
- Article
15
FDA Approves Lenvima plus Keytruda Combo for Advanced Renal-Cell Carcinoma.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 6
- Publication type:
- Article
16
Exkivity Receives Accelerated Approval for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 6
- Publication type:
- Article
17
Lisaftoclax Demonstrates Preliminary Efficacy and Tolerability in Relapsed or Refractory CLL/SLL.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 1
- By:
- Publication type:
- Article
18
Breast Reconstruction Disparities Improve Significantly with Medicaid Expansion.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 1
- By:
- Publication type:
- Article
19
Balstilimab Shows Promise in the Treatment of Advanced Cervical Cancer.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 1
- By:
- Publication type:
- Article
20
Olaparib, a PARP Inhibitor, Prolongs Disease-Free Survival in Patients with Early-Stage Breast Cancer and BRCA Mutation.
- Published in:
- Value-Based Cancer Care, 2021, v. 12, n. 5, p. 1
- By:
- Publication type:
- Article